We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Yearly Mammograms Starting at 40 Saves More Lives

By HospiMedica International staff writers
Posted on 15 Feb 2011
A new study questions current breast cancer screening recommendations with data that shows starting at a younger age and screening more frequently results in many more lives saved.

Researchers at the University of Colorado School of Medicine (Aurora, CO, USA) and the University of Michigan Comprehensive Cancer Center (UMCCC; Ann Arbor, MI, USA) conducted a study to examine the scientific evidence considered by the United States Preventive Services Task Force (USPSTF; Rockville, MD, USA) in recommending against screening mammography in women 40-49 years old, and against annual screening mammography in women 50 and older.

To do so, they used the same evidence made available to the USPSTF to estimate the benefits and harms of screening mammography in women 40 years old and older. More...
They then used six model scenarios of screening mammography created by the Cancer Intervention and Surveillance Modeling Network to compare lives saved by different screening scenarios, and the summary of evidence prepared for the USPSTF to estimate the frequency of harms of screening mammography by age. They also compared task force guidelines to the American Cancer Society (Atlanta, GA, USA) guidelines.

The researchers found that when averaged over the six models, screening mammography shows greatest benefit from annual screening of women 40-84 years old. This screening regimen saves 71% more lives than the USPSTF-recommended regimen of biennial screening of women 50-74 years old, which had a 23.2% mortality reduction. According to these results, for US women currently aged 30-39 years old, annual screening mammography starting at 40 years would save 99,829 more lives than USPSTF recommendations (if all women complied). Potential harms of a screening examination in women 40-49 years old, on average, consist of a false-positive mammogram once every 10 years; recall for more tests once every 12 years, and a false-positive biopsy once every 149 years. The study was published in the February 2011 issue of the American Journal of Roentgenology.

"The task force overemphasized potential harms of screening mammography, while ignoring the proven statistically significant benefit of annual screening mammography starting at age 40,” said coauthor R. Edward Hendrick, PhD, a clinical professor of radiology. "In addition, the panel ignored more recent data from screening programs in Sweden and Canada showing that 40% of breast cancer deaths are averted in women who get regular screening mammography.”

"Task force guidelines have created confusion among women, leading some to forego mammography altogether,” added coauthor Mark Helvie, MD, director of breast imaging at the UMCCC. "Mammography is one of the few screening tools that has been proven to save lives, and our analysis shows that for maximum survival, annual screening beginning at 40 is best.”

Related Links:
University of Colorado School of Medicine
University of Michigan Comprehensive Cancer Center
United States Preventive Services Task Force
American Cancer Society




Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.